IP Library Granted Patent US 12,007,354
Granted Patent B2
US 12,007,354 · App. 17/090,982 · Granted Jun 11, 2024

Rapid detection and identification of bacteria with graphene field effect transistors and peptide probes

Inventors: Kenneth S. Burch (Brighton, MA); Tim van Opijnen (Somerville, MA); Jianmin Gao (Newton, MA); Narendra Kumar (Brighton, MA); Juan C. Ortiz-Marquez (Brighton, MA); Wenjian Wang (Brighton, MA); Mason Gray (Chestnut Hill, MA)
Assignee: The Trustees of Boston College
G01N27/4145G01N27/4146G01N27/4148
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,007,354
App. No.
17/090,982
Granted
Jun 11, 2024
Kind
B2
Abstract

A method and system for label-free detection of pathogenic and antibiotic resistant bacteria is disclosed. The method includes fabricating a G-FET/peptide device having a synthesized peptide probe capable of recognizing and binding to a bacterial target; performing electric-field assisted binding of at least one bacterial cell of the bacterial target to the G-FET/peptide device; and electrically detecting the binding of the at least one bacterial cell to the G-FET/peptide device.

Claims (25)

1. A label-free bacteria detection system, comprising:

a graphene field effect transistor (G-FET)/peptide device capable of biosensing using dielectrophoresis and comprising a peptide probe formed of a chemically modified peptide conjugated to a flat aromatic linker and capable of recognizing and binding to a bacterial target integrated on the G-FET, wherein the G-FET comprises a defect-free graphene monolayer fabricated into a field effect transistor having electrical contacts insulated from a defined sensing area.

2. The device of claim 1 , wherein the bacterial target is pathogenic bacteria.

3. The device of claim 1 , wherein the bacterial target is an antibiotic resistant bacterial strain.

4. The device of claim 1 , wherein the peptide probe is bacterial species specific.

5. The device of claim 1 , wherein the peptide probe is bacterial strain specific.

6. The device of claim 1 , wherein the G-FET/peptide device is stable at room temperature.

7. The device of claim 1 , wherein the bacterial target includes S. aureus (ATCC 6538), wild-type A. baumannii (AB5075), A. baumannii (5075 LOS-), B. subtilis , or E. coli.

8. A method for the label-free detection of bacteria, comprising:

fabricating a defect-free graphene monolayer into a graphene field effect transistor (G-FET) having electrical contacts insulated from a defined sensing area;

synthesizing a chemically modified peptide and conjugating the synthesized peptide to a flat aromatic linker to create a peptide probe capable of recognizing and binding to a bacterial target;

integrating the peptide probe on the G-FET to provide a G-FET/peptide device capable of biosensing using dielectrophoresis;

performing electric-field assisted binding of at least one bacterial cell of the bacterial target to the defined sensing area of the G-FET/peptide device; and

electrically detecting the binding of the at least one bacterial cell to the G-FET/peptide device.

9. The method of claim 8 , wherein electrically detecting the binding of the at least one bacterial cell comprises monitoring changes in the Dirac voltage.

10. The method of claim 8 , wherein the at least one bacterial cell is pathogenic bacteria.

11. The method of claim 8 , wherein the at least one bacterial cell is an antibiotic resistant bacterial strain.

12. The method of claim 8 , wherein the peptide probe is bacterial species specific.

13. The method of claim 8 , wherein the peptide probe is bacterial strain specific.

14. The method of claim 8 , wherein the G-FET/peptide device is stable at room temperature.

15. The method of claim 8 , wherein the at least one bacterial cell includes S. aureus (ATCC 6538), wild-type A. baumannii (AB5075), A. baumannii (5075 LOS-), B. subtilis , or E. coli.

16. The method of claim 8 , wherein the method has a sensitivity including a detection limit to 10 4 cells/ml and detection time to below 5 minutes.

17. The method of claim 8 , wherein electrically detecting the binding of the at least one bacterial cell includes determining the concentration of the at least one bacterial cell bound to the G-FET/peptide device.

18. The method of claim 8 , further comprising:

wherein integrating the peptide probe on the G-FET comprises a single-step attachment of the linker molecule peptide probe to the G-FET.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 26, 2023
From: BOSTON COLLEGE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065358/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: BURCH, KENNETH S.; VAN OPIJNEN, TIM; GAO, JIANMIN; KUMAR, NARENDRA; ORTIZ-MARQUEZ, JUAN C.; WANG, WENJIAN; GRAY, MASON
To: THE TRUSTEES OF BOSTON COLLEGE
Reel/Frame 054293/0917 →
Continuity (2)
Provisional Application 62932832 · Nov 8, 2019
Related Publication 20210140919A1 · May 13, 2021